选择地区
Menu
  • 产品和解决方案more
    • 重症监护
    • 心血管治疗
    • 手术室
    • 无菌再处理
    • 数字医疗
    • 制药生产
    • 科研实验室

    • 查看所有产品 →
  • 服务more
    • 技术服务
    • 数字化服务
    • 融资服务
    • 计划 &设计
    • 项目实施
    • 教育 & 培训
    • 医院转型伙伴关系

    • 了解所有 Getinge 服务 →
  • 洞察力more
    • 文章
    • 活动
    • Getinge 体验中心

    • 行业洞察主页 →
  • 公司more
    • 公司治理
    • 可持续发展
    • 商业道德
    • 新闻
    • 职业
    • Investors
    • Grants and Charitable Donations
    • 历史

    • 公司主页 →
    • 新闻
    • 法律信息
    • 产品目录
    • COVID-19 Resource Center
    • Investors
    • Careers
  • 联系我们
  • 中国 (中文)
    • Global
      • International (English)
    • EMEA
      • Sverige (Svenska)
      • Deutschland (Deutsch)
      • France (Français)
      • United Kingdom / Ireland (English)
      • Italia (Italiano)
      • Türkiye (Türkçe)
      • Polska (polski)
      • Россия (русский)
      • Spain (Español)
      • Denmark (Dansk)
      • Norge (Norsk)
      • Suomi (Suomalainen)
      • Benelux (Nederlands)
    • Americas
      • United States (English)
      • Brazil (Português)
      • Canada (English)
      • Canada (Français)
      • Latin America (Español)
    • Asia
      • 日本 (日本語)
      • 中国 (中文)
      • 한국어(대한민국)
      • South East Asia (English)
      • India (English)
    • Oceania
      • Australia / New Zealand (English)
  • 产品和解决方案
    • 重症监护
    • 心血管治疗
    • 手术室
    • 无菌再处理
    • 数字医疗
    • 制药生产
    • 科研实验室

    • 查看所有产品 →
  • 服务
    • 技术服务
    • 数字化服务
    • 融资服务
    • 计划 &设计
    • 项目实施
    • 教育 & 培训
    • 医院转型伙伴关系

    • 了解所有 Getinge 服务 →
  • 洞察力
    • 文章
    • 活动
    • Getinge 体验中心

    • 行业洞察主页 →
  • 公司
    • 公司治理
    • 可持续发展
    • 商业道德
    • 新闻
    • 职业
    • Investors
    • Grants and Charitable Donations
    • 历史

    • 公司主页 →
  • 联系我们
  • 开始
  • 公司
  • 公司治理
  • General meetings

General meetings

The General Meeting of Shareholders is Getinge’s highest decision-making body through which the Shareholders exercise their influence over the company. The Annual General Meeting is held annually within six months of the end of the financial year and Shareholders can at the Annual General Meeting exercise their voting rights on various key matters. The Board can also convene and Extraordinary General Meeting.

  • Overview
  • Article of association
  • General meetings
  • 政策
  • Board of directors
  • Nomination committee
  • External auditor
  • Remuneration
  • Executive team
  • Corporate governance and auditor's reports
  • Board committees

Participation

Shareholders who wish to participate in and vote for their shares at the General Meeting must be registered in the share register and notify their participation.* Shareholders who are unable to attend in person may be represented by a proxy.

Location

Getinge's Annual General Meeting is held in Gothenburg or Halmstad no later than six months after the end of the financial year. The time and venue for the meeting are announced, at the latest, in connection with the interim report for the third quarter.

Notice to Attend

The notice to attend the General Meeting is published 4-6 weeks before the meeting in Post- och Inrikes Tidningar and on the company's website. An announcement that the notice to attend has been published is made in Svenska Dagbladet.

* The notice of participation to attend the General Meeting specifies how to give notice to the company and provides other information about participation in the General Meeting. The notice must be received within a certain time prior to the general meeting.

Matters at the Annual General Meeting

The Shareholders are informed about the development of the company during the past year. Key matters addressed at the Annual General Meeting are, for example, decisions made regarding the company and group's income statements and balance sheets, allocation of the company's profit, discharge from liability for the Board members and CEO, election of and remuneration for the Board members and the auditors, and any other issues in accordance with law or the articles of association.

Matters by request of Shareholders

A Shareholder is entitled to have a matter addressed at the General Meeting, provided that the board has received such request no later than one week before the notice to attend may be published at the earliest. The matter will be addressed also if the request is received later than said time, if the matter can be included in the notice to attend. A Shareholder who wishes to have a matter considered by the General Meeting must submit a written proposal to the meeting.

Extraordinary Shareholders Meeting

An Extraordinary General Meeting may be convened at the discretion of the Board of Directors, or if the auditors or a Shareholder who own no less then 10% of the shares request such meeting to be held. Matters to be handled on such meeting should be specified in writing in the request.

Annual General Meeting 2025

了解更多

Annual General Meeting 2024

了解更多

Annual General Meeting 2023

了解更多

Annual General Meeting 2022

了解更多

Annual General Meeting 2021

了解更多

Annual General Meeting 2020

了解更多

Annual General Meeting 2019

了解更多

Annual General Meeting 2018

了解更多

Extraordinary General Meeting December 2017

了解更多

Extraordinary General Meeting August 2017

了解更多

Annual General Meeting 2017

了解更多

Annual General Meeting 2016

了解更多

Annual General Meeting 2015

了解更多

Annual General Meeting 2014

了解更多

Annual General Meeting 2013

了解更多

Annual General Meeting 2012

了解更多

Annual General Meeting 2011

了解更多

Annual General Meeting 2010

了解更多

Annual General Meeting 2009

了解更多

您现在正离开Getinge.com。您可能会访问非Getinge团队管理的内容,在这种情况下,Getinge对这些内容不负责任。 

我明白!

我们能提供

  • 服务
  • 产品和解决方案

辅助工具栏

  • 洞察力
  • 活动
  • 过往网络研讨会
  • 使用说明/患者信息
  • 安全性

关于我们

  • 投资
  • 职业
  • 公司治理
  • 历史
  • 法律信息
  • 隐私政策
  • 网站免责声明
  • Cookie 注意事项
  • 数据主体申请表
取得联系
中国 (中文)
  • Global
    • International (English)
  • EMEA
    • Sverige (Svenska)
    • Deutschland (Deutsch)
    • France (Français)
    • United Kingdom / Ireland (English)
    • Italia (Italiano)
    • Türkiye (Türkçe)
    • Polska (polski)
    • Россия (русский)
    • Spain (Español)
    • Denmark (Dansk)
    • Norge (Norsk)
    • Suomi (Suomalainen)
    • Benelux (Nederlands)
  • Americas
    • United States (English)
    • Brazil (Português)
    • Canada (English)
    • Canada (Français)
    • Latin America (Español)
  • Asia
    • 日本 (日本語)
    • 中国 (中文)
    • 한국어(대한민국)
    • South East Asia (English)
    • India (English)
  • Oceania
    • Australia / New Zealand (English)
中国 (中文)

© 2025 Getinge │ Getinge 以及 

Getinge_Logo_hz_RGB_neg.png

为 Getinge AB 及其子公司或附属公司的商标或注册商标 │版权所有

十一月 2024

此类信息仅供专业医疗人士或其他专业受众参考。信息并未详尽,不可取代使用说明、服务手册或医疗建议。对于任一方基于本材料的作为或不作为,Getinge 均不承担任何责任或义务。依赖此类信息的使用风险完全由用户个人承担。

所提及的疗法、解决方案或产品可能在您的国家无法使用或被禁止使用。未经 Getinge 书面许可,不得复制或使用全部或部分信息。

 

本信息面向美国地区以外的国际受众。

所表达的观点、意见和论断完全为受访者观点,不一定反映或代表 Getinge 的观点。